TransDigm has delivered its fiscal Q4 results, and the reaction tells a clear story: the numbers landed below enough expectations to prompt fresh downgrades, leaving the stock down 2.5% on the week at $1,275 and off more than 5% over the past month.
The most decisive post-earnings move came from Stifel, which downgraded TDG to Hold from Buy on August 5 and cut its target from $1,525 to $1,405. That follows Morgan Stanley's step to the sidelines on July 15 — analyst Kristine Liwag moved to Equal-Weight from Overweight, slashing her target from $1,680 to $1,345. Two downgrades in three weeks from houses that were previously positive is a meaningful shift in tone. BMO Capital remains the clearest bull, having raised its target to $1,525 in early July while keeping an Outperform rating. The mean target now sits near $1,517, implying roughly 19% upside from current levels — but with the recent direction of analyst revisions pointing down, the Street is becoming more selective rather than more constructive. The PE multiple has compressed about 2.5 points over the past 30 days, now running near 28.4x, while the EV/EBITDA has eased to roughly 17x.
The bull and bear cases have sharpened post-results. Bears are focused on the FY2026 EBITDA guidance of $5.15 billion, which came in below expectations, alongside a projected 140 basis point year-over-year margin decline tied to acquisition integration and mix headwinds from the recently acquired Simmonds business. Bulls counter that commercial OE demand remains robust — high single-digit to mid-teens growth guided — and the company delivered 160 basis points of margin expansion in the most recent comparable period. That tension between near-term margin pressure and durable structural demand is the central debate the stock is now trading around.
Positioning in the lending market offers no additional drama. Short interest is genuinely low at 1.8% of the free float, and has been falling — down 12% over the past month. The borrow pool is extremely loose, with availability at over 4,000%, meaning there are roughly 40 shares available for every one currently lent out. Cost to borrow doubled week-over-week to 0.67%, but in absolute terms that is barely worth noting. The options market tells a mildly cautious story: the put/call ratio is running at 1.63, above its 20-day average of 1.35, though the z-score of 0.48 keeps this well short of a genuine alarm signal. Through July, the PCR touched as high as 2.19 before easing — the recent decline suggests some defensive hedging from the pre-earnings period has started to unwind.
Founder and Chairman Walter Howley sold approximately $7.2 million worth of shares across multiple tranches on July 20, at prices around $1,210–$1,220. Individually none of the tranches were large relative to his stake, but the cluster of sales into pre-earnings strength — at prices now above the current level — is at minimum worth noting as context. The 90-day net insider position is a net sale of roughly $14.9 million worth of shares, with no offsetting purchases on record in the window. Institutional ownership is concentrated and largely stable: Capital Research holds 24% of shares and added modestly last quarter, while BlackRock added around 303,000 shares through June. The ownership base is not signalling distress — it's simply not adding conviction here either.
The peer group is moving in the opposite direction. LOAR gained 5.5% on the week, VSEC rose 7.5%, and GE added 3.8%. HEI was roughly flat. TDG's underperformance this week is therefore specific rather than sectoral — the results and the guidance revision are doing the work. The next scheduled earnings event is November 10, which gives the company roughly three months to demonstrate whether the margin headwinds from Simmonds are transitory or structural. That question — and whether management's commercial OE growth forecast materialises through Q1 FY2027 — is what the revised analyst targets will ultimately be measured against.
See the live data behind this article on ORTEX.
Open TDG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
